Department of Embryology, Medical University of Gdansk, Debinki 1 St, 80-210, Gdansk, PL, Poland.
Department of Laboratory Medicine, Medical University of Gdansk, Debinki 7 St, 80-211, Gdansk, PL, Poland.
J Cancer Res Clin Oncol. 2019 Jan;145(1):165-179. doi: 10.1007/s00432-018-2776-4. Epub 2018 Oct 26.
As a continuation of our search for anticancer agents, we have synthesized a new acridine-retrotuftsin analog HClx9-[Arg(NO)-Pro-Lys-Thr-OCH]-1-nitroacridine (named ART) and have evaluated its activity against melanoma and neuroblastoma lines. Both tumors develop from cells (melanocytes, neurons) of neuroectodermal origin, and both are tumors with high heterogeneity and unsatisfactory susceptibility to chemotherapies. Thus, we analyzed the action of ART on pairs of biological forms of melanoma (amelanotic and melanotic) and neuroblastoma (dopaminergic and cholinergic) with regard to proliferation, mechanism of cell death, and effect on the activity of tricarboxylic acid cycle (TAC) enzymes.
The cytotoxicity of ART was evaluated by XTT and trypan blue tests. Cell death was estimated by plasma membrane structure changes (phosphatidylserine and calreticulin externalization), caspase activation, presence of ROS (reactive oxygen species), activity of tricarboxylic acid cycle enzymes (pyruvate dehydrogenase complex, aconitase, and isocitrate dehydrogenase), NAD level, and ATP level.
ART influences the biological forms of melanoma and neuroblastoma in different ways. Amelanotic (Ab) melanoma (with the inhibited melanogenesis, higher malignancy) and SHSY5Y neuroblastoma (with cholinergic DC cells) were especially sensitive to ART action. The Ab melanoma cells died through apoptosis, while, with SH-SY5Y-DC neuroblastoma, the number of cells decreased but not as a result of apoptosis. With Ab melanoma and SH-SY5Y-DC cells, a diminished activity of TAC enzymes was noticed, along with ATP/NAD depletion.
Our data show that the biological forms of certain tumors responded in different ways to the action of ART. As a combination of retrotuftsin and acridine, the compound can be an inducer of apoptotic cell death of melanoma, especially the amelanotic form. Although the mechanism of the interrelationships between energy metabolism and cell death is not fully understood, interference of ART with TAC enzymes could encourage the further investigation of its anticancer action.
作为我们寻找抗癌药物的延续,我们合成了一种新的吖啶-反转短肽类似物 HClx9-[Arg(NO)-Pro-Lys-Thr-OCH]-1-硝基吖啶(命名为 ART),并评估了其对黑色素瘤和神经母细胞瘤系的活性。这两种肿瘤均起源于神经外胚层细胞(黑色素细胞、神经元),且均为异质性高、对化疗敏感性差的肿瘤。因此,我们分析了 ART 对黑色素瘤(无黑色素和黑色素)和神经母细胞瘤(多巴胺能和胆碱能)的两对生物形态的作用,包括增殖、细胞死亡机制以及对三羧酸循环(TAC)酶活性的影响。
通过 XTT 和台盼蓝试验评估 ART 的细胞毒性。通过质膜结构变化(磷脂酰丝氨酸和钙网蛋白外化)、半胱天冬酶激活、ROS(活性氧)存在、三羧酸循环酶(丙酮酸脱氢酶复合物、顺乌头酸酶和异柠檬酸脱氢酶)活性、NAD 水平和 ATP 水平来估计细胞死亡。
ART 以不同的方式影响黑色素瘤和神经母细胞瘤的生物形态。无黑色素(Ab)黑色素瘤(黑色素生成受抑制,恶性程度更高)和 SHSY5Y 神经母细胞瘤(具有胆碱能 DC 细胞)对 ART 作用特别敏感。Ab 黑色素瘤细胞通过细胞凋亡死亡,而 SH-SY5Y-DC 神经母细胞瘤细胞数量减少,但不是由于细胞凋亡。Ab 黑色素瘤和 SH-SY5Y-DC 细胞中,TAC 酶活性降低,同时 ATP/NAD 耗尽。
我们的数据表明,某些肿瘤的生物形态对 ART 的作用有不同的反应。作为反转短肽和吖啶的组合,该化合物可以诱导黑色素瘤,特别是无黑色素的细胞凋亡。虽然能量代谢与细胞死亡之间的相互关系的机制尚未完全阐明,但 ART 对 TAC 酶的干扰可能会鼓励进一步研究其抗癌作用。